Introduction: Diabetes increases the risk of morbidity and death in pregnant women and newborns. One of the most frequent perinatal issues in diabetic pregnancies is fetal macrosomia, especially in mothers with poor glycemic control.
Aim of the study: This study aimed to ascertain the relationship between neonatal B.W. and maternal blood lipid levels, specifically T.C. and T.G. levels. Additionally, the capacity of T.G. and T.C. levels to forecast macrosomia was examined.
Subjects and Methods: 150 pregnant women, 75 of whom had type 2 diabetes and 75 of whom had gestational diabetes, participated in this observational cohort research at a third trimester GA of 29 to 40 weeks. The lipid parameters listed below were measured.
Results: Age, height, weight, B.M.I., F.B.G., 2HPPBG, HbA1c, parity LDL, newborn weight, and gestational age are not significantly different between the type 2DM group and the G.D.M. group (P > 0.05). On the other hand, there was a statistically significant difference in T.C., T.G., and HDL between the type 2 DM and G.D.M. groups. In the type 2DM group. Conclusions: This study showed the value of assessing fasting serum T.G. levels throughout the third trimester of pregnancy, which is strongly linked with neonatal B.W. and may be used as a standalone predictor of fetal macrosomia at term in type 2 DM and G.D.M.